Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation
GlaxoSmithKline (United Kingdom) · Age UK · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
753
total citations
- FWCI
- 20.14
- Percentile
- 100%
- References
- 36
Citations per year
Authors
33- HDHuw D. LewisCorresponding
GlaxoSmithKline (United Kingdom), Age UK
- JLJohn Liddle
GlaxoSmithKline (United Kingdom), Age UK
- JCJim Coote
GlaxoSmithKline (United Kingdom), Molecular Discovery (United Kingdom)
- SJStephen J. Atkinson
GlaxoSmithKline (United Kingdom), Age UK
- MDMichael D. Barker
GlaxoSmithKline (United Kingdom), Age UK
Topics & keywords
Topics
Keywords
- Neutrophil extracellular traps
- Citrullination
- Pathogenesis
- Extracellular
- Histone
- Cell biology
- Gene
- Enzyme
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.